Effect of L-asparaginase therapy upon serum pseudocholinesterase and ceruloplasmin levels in patients with acute leukemia.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D001215:Asparaginase / Q000627:therapeutic use*; D002570:Ceruloplasmin / Q000097:blood*; D002802:Cholinesterases / Q000097:blood*; D005260:Female; D006801:Humans; D007700:Kinetics; D007938:Leukemia / Q000188:drug therapy* / Q000201:enzymology; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000201:enzymology; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000201:enzymology; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000201:enzymology; D008297:Male; D008875:Middle Aged
D002570:Ceruloplasmin; D002802:Cholinesterases; D001215:Asparaginase